MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Estrogen and related hormone effects
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,795 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,795 works in the cohort · of 4,299,418page 19 of 36

Labels cover 7 of 1,795 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,795 of 1,795 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
15-year outcomes for women with premenopausal hormone receptor-positive early breast cancer (BC) in the SOFT and TEXT trials assessing benefits from adjuvant exemestane (E) + ovarian function suppression (OFS) or tamoxifen (T)+OFS.
Prudence A. Francis, Gini F. Fleming, Olivia Pagani, Barbara Walley, Sherene Loi, Marco Colleoni +1 more
2025· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
16
citations
affno abstractunlabeled
Characterization of estrogen receptor β2 and expression of the estrogen receptor subtypes α, β1, and β2 in the protandrous black porgy (Acanthopagrus schlegeli) during the sex change process
Kwang Wook An, Erik R. Nelson, Pil Gue Jo, Hamid R. Habibi, Hyun Suk Shin, Cheol Young Choi
2008· article· en· Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
16
citations
affno abstractunlabeled
The thyroid C cells of ovariectomized rats treated with estradiol
Branko Filipović, Nataša Nestorović, Milica Manojlović‐Stojanoski, Nada Kostić, Verica Milošević, M. Sekulić
2003· article· en· Histochemistry and Cell Biology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
16
citations
affno abstractunlabeled
SEX CHROMATIN IN VARIOUS MAMMALS
Jean C. Hay, Keith L. Moore
2008· article· en· Acta Anatomica· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
15
citations

How this was built: Screen · Findings · About